COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample
Description
COVID-19 convalescent plasma (CCP) use between October-December 2020 was characterized using the National Inpatient Sample database. CCP was administered in 18.0% of COVID-19-associated hospitalizations, and was strongly associated with older age and